copyright and Wegovy, two recent breakthroughs in the field of weight management, have captured significant attention for their impressive results. These medications, both belonging to a class called GLP-1 receptor agonists, work by enhancing the body's natural processes to minimize appetite and improve insulin sensitivity. Early clinical trials h